These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9299818

  • 21. Differential effects of ammonia on the benzodiazepine modulatory site on the GABA-A receptor complex of human brain.
    Ahboucha S, Araqi F, Layrargues GP, Butterworth RF.
    Neurochem Int; 2005 Jul; 47(1-2):58-63. PubMed ID: 15913842
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Relationship between hepatic injury status and event related potentials.
    Tarter RE, Sclabassi RJ, Sandford SL, Hays AL, Carra JP, Van Thiel DH.
    Clin Electroencephalogr; 1987 Jan; 18(1):15-9. PubMed ID: 3829431
    [Abstract] [Full Text] [Related]

  • 24. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P, Grimm G.
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma.
    Ahboucha S, Pomier-Layrargues G, Mamer O, Butterworth RF.
    Neurochem Int; 2006 Sep; 49(4):372-8. PubMed ID: 16563564
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of a single, short intravenous dose of acetyl-L-carnitine on pattern-reversal visual-evoked potentials in cirrhotic patients with hepatic encephalopathy.
    Siciliano M, Annicchiarico BE, Lucchese F, Bombardieri G.
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(1-2):76-80. PubMed ID: 16445703
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Parkinson's disease. Clinical and electrophysiological evaluation.
    Al-Bunyan MA.
    Saudi Med J; 2000 Jan; 21(1):72-5. PubMed ID: 11533754
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Event-related cerebral potentials for the diagnosis of subclinical hepatic encephalopathy in patients with liver cirrhosis.
    Ciećko-Michalska I, Senderecka M, Szewczyk J, Panasiuk A, Słowik A, Wyczesany M, Binder M, Mach T.
    Adv Med Sci; 2006 Jan; 51():273-7. PubMed ID: 17357325
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ, Bansky G.
    Schweiz Med Wochenschr; 1990 Apr 14; 120(15):553-6. PubMed ID: 2159659
    [Abstract] [Full Text] [Related]

  • 36. Somatosensory amplification and its relationship to somatosensory, auditory, and visual evoked and event-related potentials (P300).
    Nakao M, Barsky AJ, Nishikitani M, Yano E, Murata K.
    Neurosci Lett; 2007 Mar 26; 415(2):185-9. PubMed ID: 17267120
    [Abstract] [Full Text] [Related]

  • 37. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
    Als-Nielsen B, Kjaergard LL, Gluud C.
    Cochrane Database Syst Rev; 2001 Mar 26; (4):CD002798. PubMed ID: 11687160
    [Abstract] [Full Text] [Related]

  • 38. An interaction between benzodiazepines and neuroactive steroids at GABA A receptors in cultured hippocampal neurons.
    Ahboucha S, Coyne L, Hirakawa R, Butterworth RF, Halliwell RF.
    Neurochem Int; 2006 Jun 26; 48(8):703-7. PubMed ID: 16487630
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.